MENU
+Compare
SAVA
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$2.36
Change
+$0.07 (+3.06%)
Capitalization
113.54M

SAVA Cassava Sciences Forecast, Technical & Fundamental Analysis

a developer of novel drugs

Industry Biotechnology
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for SAVA with price predictions
Dec 20, 2024

SAVA in downward trend: price dove below 50-day moving average on November 22, 2024

SAVA moved below its 50-day moving average on November 22, 2024 date and that indicates a change from an upward trend to a downward trend. In of 42 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 22, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on SAVA as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for SAVA moved below the 200-day moving average on December 10, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SAVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SAVA entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for SAVA just turned positive on December 16, 2024. Looking at past instances where SAVA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SAVA advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

SAVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.678) is normal, around the industry mean (14.529). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). SAVA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (255.281).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SAVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SAVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SAVA is expected to report earnings to fall 17.81% to -47 cents per share on March 04

Cassava Sciences SAVA Stock Earnings Reports
Q4'24
Est.
$-0.48
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.54
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.02
The last earnings report on November 07 showed earnings per share of -57 cents, beating the estimate of -73 cents. With 3.20M shares outstanding, the current market capitalization sits at 113.54M.
A.I.Advisor
published Dividends

SAVA paid dividends on December 24, 2012

Cassava Sciences SAVA Stock Dividends
А dividend of $0.75 per share was paid with a record date of December 24, 2012, and an ex-dividend date of December 13, 2012. Read more...
A.I. Advisor
published General Information

General Information

a developer of novel drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
6801 N. Capital of Texas Highway
Phone
+1 512 501-2444
Employees
29
Web
https://www.cassavasciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNOF1.260.02
+1.61%
Verano Holdings Corp.
MKKGY28.720.15
+0.53%
Merck KGaA
MAKSY9.470.03
+0.32%
Marks & Spencer Group Plc
TRUMY19.370.05
+0.26%
Terumo Corp.
AICOF0.08N/A
-2.35%
Generative AI Solutions Corp.

SAVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SAVA has been loosely correlated with CRSP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SAVA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAVA
1D Price
Change %
SAVA100%
+2.62%
CRSP - SAVA
35%
Loosely correlated
+0.83%
IBRX - SAVA
29%
Poorly correlated
-1.87%
ATXI - SAVA
27%
Poorly correlated
-1.67%
LXRX - SAVA
26%
Poorly correlated
-1.23%
AMRN - SAVA
26%
Poorly correlated
-1.18%
More